A new study published in Clinical & Experimental Ophthalmology found that faricimab was effective in treating patients with neovascular age-related macular degeneration (nAMD) who had not previously ...
Toripalimab plus chemotherapy significantly improved progression-free survival and overall survival over chemotherapy alone in patients with advanced NSCLC while having a manageable safety profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results